- Home
- NXT vs RVMD Comparison
NXT vs RVMD Comparison
Compare NXT & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NXT | RVMD |
|---|---|---|
| Founded | 2013 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.9B | 15.2B |
| IPO Year | 2023 | N/A |
Fundamental Metrics
Financial Performance| Metric | NXT | RVMD |
|---|---|---|
| Price | $119.86 | $94.85 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 20 | 16 |
| Target Price | $107.70 | ★ $114.63 |
| AVG Volume (30 Days) | ★ 1.7M | 1.6M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 2.97 | N/A |
| EPS | ★ 2.86 | N/A |
| Revenue | ★ $2,959,197,000.00 | N/A |
| Revenue This Year | $19.73 | N/A |
| Revenue Next Year | $11.74 | $454.85 |
| P/E Ratio | $40.37 | ★ N/A |
| Revenue Growth | ★ 18.38 | N/A |
| 52 Week Low | $36.06 | $29.17 |
| 52 Week High | $131.59 | $124.49 |
Technical Indicators
Market Signals| Indicator | NXT | RVMD |
|---|---|---|
| Relative Strength Index (RSI) | 59.00 | 39.16 |
| Support Level | $111.03 | $93.59 |
| Resistance Level | $130.17 | $107.45 |
| Average True Range (ATR) | 5.24 | 3.80 |
| MACD | 0.69 | -0.82 |
| Stochastic Oscillator | 84.77 | 1.39 |
Price Performance
Historical ComparisonAbout NXT Nextracker Inc.
Nextpower (and its subsidiaries) is a leading provider of intelligent, integrated solar tracker and software solutions used in utility-scale and distributed generation solar projects around the world. Nextpower's products enable solar panels in utility-scale power plants to follow the sun's movement across the sky and optimize plant performance. Nextpower has operations in the United States, Mexico, Spain and other countries in Europe, India, Australia, the Middle East, Africa, and Brazil.
About RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.